Cited by 5Reproductive tract infections researchAntifungal resistance and susceptibilityGynecological conditions and treatments

Update on recurrent vulvovaginal candidiasis

Borland, Amy, Ovens, Katie, Offiah, Ifeoma, Dua, Anupreet, Freeman, Robert·2021·The Obstetrician & Gynaecologist

Abstract

Key Content Recurrent vulvovaginal candidiasis (RVVC) affects millions of women worldwide. Defined as four or more episodes per year of vulvovaginal candidiasis (VVC), it is a cause of significant morbidity, affecting quality of life, relationships and ability to work. RVVC is uncommon in prepubertal girls and the incidence markedly declines following menopause. Some gynaecologists and trainees have unmet training needs in the optimal assessment and management of RVVC. A multifaceted approach is often required, including vulval skin care, avoidance of triggers and induction and suppression regimes with antifungal drugs. This review combines the current literature on VVC, incorporating data on novel therapies with established standard management protocols. Learning objectives To be able to assess risk factors and correctly diagnose VVC. To know the current management strategies for RVVC and the efficacy of novel therapies. To be aware of the common differentials of bacterial vaginosis and trichomonas vaginalis and their recommended management.

Integrity signals

Registry

Crossref · 10.1111/tog.12772

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Borland, A., Ovens, K., Offiah, I., Dua, A., & Freeman, R.
Affiliations
University Hospitals Plymouth NHS Trust (GB)
Corresponding author
  • Borland, Amy
  • Ovens, Katie
  • Offiah, Ifeoma
  • Dua, Anupreet
  • Freeman, Robert
Venue
The Obstetrician & Gynaecologist
Publisher
Wiley
Published
2021-09-23
Volume
23
Issue
4
Pages
295-300
ISSN
  • 1467-2561 (ISSN-L)
  • 1744-4667
OpenAlex
W3197792919
Cited by
5
References
28
Citations by year
2026: 2 · 2025: 1 · 2023: 1 · 2022: 1
FWCI
0.35
Type
journal article
Language
en
Open access
closed
Locations
The Obstetrician & Gynaecologist (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
recurrent vulvovaginal candidiasis, vaginal candidiasis, antifungal therapy, induction therapy, maintenance therapy, risk factors, precipitating factors, bacterial vaginosis, Trichomonas vaginalis, differential diagnosis, menopause, quality of life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review